Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC.
Saved in:
| Title: | Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC. |
|---|---|
| Authors: | Sugawara S; Department of Pulmonary Medicine, Sendai Kousei Hospital, Miyagi, Japan., Nakagawa K; Department of Medical Oncology, Faculty of Medicine, Kindai University, Osaka, Japan., Yamamoto N; Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan., Nokihara H; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Ohe Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Nishio M; Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan., Takahashi T; Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Goto K; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Maemondo M; Department of Respiratory Medicine, Miyagi Cancer Center, Miyagi, Japan., Ichinose Y; Department of Cancer Information Research, National Kyushu Cancer Center, Clinical Research Institute, Fukuoka, Japan., Seto T; Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan., Sakai H; Department of Thoracic Oncology, Saitama Cancer Center, Saitama, Japan., Gemma A; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan., Imamura F; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Shingyoji M; Division of Respirology, Chiba Cancer Center, Chiba, Japan., Saka H; Department of Respiratory Medicine and Medical Oncology, National Hospital Organization Nagoya Medical Center, Aichi, Japan., Inoue A; Department of Palliative Medicine, Tohoku University School of Medicine, Miyagi, Japan., Takeda K; Department of Medical Oncology, Osaka City General Hospital, Osaka, Japan., Okamoto I; Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Kiura K; Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Okayama, Japan., Morita S; Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan., Tamura T; Thoracic Center, St Luke's International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo, 104-8560, Japan. tamuratomohide@gmail.com. |
| Source: | International journal of clinical oncology [Int J Clin Oncol] 2019 May; Vol. 24 (5), pp. 485-493. Date of Electronic Publication: 2019 Mar 04. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1437-7772 |
|---|---|
| DOI: | 10.1007/s10147-019-01396-z |
